Top

The International Journal of Cardiovascular Imaging

Published in:

01-07-2019 | Original Paper

Procedural findings and early healing response after implantation of a self-apposing bioresorbable scaffold in coronary bifurcation lesions

Authors: Emil Nielsen Holck, Camilla Fox-Maule, Trine Ørhøj Barkholt, Lars Jakobsen, Shengxian Tu, Michael Maeng, Jouke Dijkstra, Evald Høj Christiansen, Niels Ramsing Holm

Published in: The International Journal of Cardiovascular Imaging | Issue 7/2019

Abstract

We aimed to evaluate feasibility, early healing and self-correcting properties of the Desolve 150 bioresorbable scaffold (BRS) implanted in bifurcation lesions, using the simple, provisional side branch (SB) stenting technique. BIFSORB pilot was a proof-of-concept study enrolling 10 patients with stable angina pectoris and a bifurcation lesion with SB ≥ 2.5 mm and less than 50% diameter stenosis. Procedure and 1-month outcome was evaluated by optical coherence tomography (OCT) to assess scaffold performance and healing patterns. Nine patients were treated with Desolve 150 BRS and one delivery to the target bifurcation failed. Thrombus formation in the jailed SB ostium was seen in three cases, but was completely resolved at 1-month. OCT confirmed acute self-correcting properties. No clinical events were reported after six months. Scaffold diameter by OCT increased in the proximal main vessel from 3.09 ± 0.16 mm to 3.34 ± 0.18 mm (p = 0.01) and in distal main vessel from 2.82 ± 0.26 mm to 3.02 ± 0.29 mm (p < 0.01) at one-month follow-up. SB ostial diameter stenosis improved from 42 ± 15% to 34 ± 12% (p = 0.01). Malapposition was effectively reduced after 1 month from 4.1 (1.4; 6.1)% to 0.1 (0; 0.6)% (p = 0.002). Treatment of bifurcation lesions using Desolve 150 BRS was feasible except for a delivery failure and unsettling thrombus formation behind jailing SB struts, which was completely resolved at 1-month. Self-correcting and even self-expanding properties were confirmed.

Available only for authorised users

Lipinski MJ, Escarcega RO, Baker NC, Benn HA, Gaglia MA Jr, Torguson R, Waksman R (2016) Scaffold thrombosis after percutaneous coronary intervention With ABSORB bioresorbable vascular scaffold: a systematic review and meta-analysis. JACC Cardiovasc Interv 9(1):12–24. https://doi.org/10.1016/j.jcin.2015.09.024 CrossRefPubMed

Latib A, Capodanno D, Lesiak M, Tamburino C, Colombo A (2015) Lessons from the GHOST-EU registry. EuroIntervention 11(Suppl V):V170–V174. https://doi.org/10.4244/EIJV11SVA41 CrossRefPubMed

Gomez-Lara J, Radu M, Brugaletta S, Farooq V, Diletti R, Onuma Y, Windecker S, Thuesen L, McClean D, Koolen J, Whitbourn R, Dudek D, Smits PC, Regar E, Veldhof S, Rapoza R, Ormiston JA, Garcia-Garcia HM, Serruys PW (2011) Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography. JACC Cardiovasc Interv 4(9):992–1001. https://doi.org/10.1016/j.jcin.2011.03.020 CrossRefPubMed

Karanasos A, Van Mieghem N, van Ditzhuijzen N, Felix C, Daemen J, Autar A, Onuma Y, Kurata M, Diletti R, Valgimigli M, Kauer F, van Beusekom H, de Jaegere P, Zijlstra F, van Geuns RJ, Regar E (2015) Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience. Circ Cardiovasc Interv. https://doi.org/10.1161/CIRCINTERVENTIONS.114.002369 CrossRefPubMedPubMedCentral

Ormiston JA, Webber B, Ubod B, Webster MW, White J (2015) Absorb everolimus-eluting bioresorbable scaffolds in coronary bifurcations: a bench study of deployment, side branch dilatation and post-dilatation strategies. EuroIntervention 10(10):1169–1177. https://doi.org/10.4244/EIJY14M05_08 CrossRefPubMed

Stankovic G, Lassen JF (2015) When and how to use BRS in bifurcations? EuroIntervention 11(Suppl V):V185–V187. https://doi.org/10.4244/EIJV11SVA44

Ormiston JA, Webber B, Ubod B, Darremont O, Webster MW (2015) An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition). EuroIntervention 11(1):60–67. https://doi.org/10.4244/EIJY15M02_03 CrossRefPubMed

Verheye S, Ormiston JA, Stewart J, Webster M, Sanidas E, Costa R, Costa JR Jr, Chamie D, Abizaid AS, Pinto I, Morrison L, Toyloy S, Bhat V, Yan J, Abizaid A (2014) A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results. JACC Cardiovasc Interv 7(1):89–99. https://doi.org/10.1016/j.jcin.2013.07.007 CrossRefPubMed

Burzotta F, Talarico GP, Trani C, De Maria GL, Pirozzolo G, Niccoli G, Leone AM, Saffioti S, Porto I, Crea F (2014) Frequency-domain optical coherence tomography findings in patients with bifurcated lesions undergoing provisional stenting. Eur Heart J Cardiovasc Imaging 15(5):547–555. https://doi.org/10.1093/ehjci/jet231 CrossRefPubMed

10.

Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, Academic Research C (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115(17):2344–2351. https://doi.org/10.1161/CIRCULATIONAHA.106.685313 CrossRefPubMed

11.

Lassen JF, Holm NR, Stankovic G, Lefevre T, Chieffo A, Hildick-Smith D, Pan M, Darremont O, Albiero R, Ferenc M, Louvard Y (2014) Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10 years of the European Bifurcation Club meetings. EuroIntervention 10(5):545–560. https://doi.org/10.4244/EIJV10I5A97 CrossRefPubMed

12.

Karanasos A, Tu S, van Ditzhuijzen NS, Ligthart JM, Witberg K, Van Mieghem N, van Geuns RJ, de Jaegere P, Zijlstra F, Reiber JH, Regar E (2015) A novel method to assess coronary artery bifurcations by OCT: cut-plane analysis for side-branch ostial assessment from a main-vessel pullback. Eur Heart J Cardiovasc Imaging 16(2):177–189. https://doi.org/10.1093/ehjci/jeu176 CrossRefPubMed

13.

Ali ZA, Serruys PW, Kimura T, Gao R, Ellis SG, Kereiakes DJ, Onuma Y, Simonton C, Zhang Z, Stone GW (2017) 2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy. Lancet 390(10096):760–772. https://doi.org/10.1016/S0140-6736(17)31470-8 CrossRefPubMed

14.

Kawamoto H, Latib A, Ruparelia N, Miyazaki T, Sticchi A, Naganuma T, Sato K, Figini F, Chieffo A, Carlino M, Montorfano M, Colombo A (2015) Clinical outcomes following bioresorbable scaffold implantation for bifurcation lesions: overall outcomes and comparison between provisional and planned double stenting strategy. Catheter Cardiovasc Interv 86(4):644–652. https://doi.org/10.1002/ccd.26045 CrossRefPubMed

15.

Mattesini A, Secco GG, Dall’Ara G, Ghione M, Rama-Merchan JC, Lupi A, Viceconte N, Lindsay AC, De Silva R, Foin N, Naganuma T, Valente S, Colombo A, Di Mario C (2014) ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance. JACC Cardiovasc Interv 7(7):741–750. https://doi.org/10.1016/j.jcin.2014.01.165 CrossRefPubMed

16.

Finet G, Derimay F, Motreff P, Guerin P, Pilet P, Ohayon J, Darremont O, Rioufol G (2015) Comparative analysis of sequential proximal optimizing technique versus kissing balloon inflation technique in provisional bifurcation stenting: fractal coronary bifurcation bench test. JACC Cardiovasc Interv 8(10):1308–1317. https://doi.org/10.1016/j.jcin.2015.05.016 CrossRefPubMed

17.

Abizaid A, Costa RA, Schofer J, Ormiston J, Maeng M, Witzenbichler B, Botelho RV, Costa JR Jr, Chamie D, Abizaid AS, Castro JP, Morrison L, Toyloy S, Bhat V, Yan J, Verheye S (2016) Serial multimodality imaging and 2-year clinical outcomes of the novel desolve novolimus-eluting bioresorbable coronary scaffold system for the treatment of single de novo coronary lesions. JACC Cardiovasc Interv 9(6):565–574. https://doi.org/10.1016/j.jcin.2015.12.004 CrossRefPubMed

18.

Serruys PW, Onuma Y (2017) Dmax for sizing, PSP-1, PSP-2, PSP-3 or OCT guidance: interventionalist’s jargon or indispensable implantation techniques for short- and long-term outcomes of Absorb BRS? EuroIntervention 12(17):2047–2056. https://doi.org/10.4244/EIJY17M02_01 CrossRefPubMed

19.

Pan M, Romero M, Ojeda S, Suarez de Lezo J, Segura J, Mazuelos F, Martin P, Medina A, Suarez de Lezo J (2015) Fracture of bioresorbable vascular scaffold after side-branch balloon dilation in bifurcation coronary narrowings. Am J Cardiol 116(7):1045–1049. https://doi.org/10.1016/j.amjcard.2015.07.015 CrossRefPubMed

20.

Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S (2008) A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 371(9616):899–907. https://doi.org/10.1016/S0140-6736(08)60415-8 CrossRefPubMed

21.

Serruys PW, Onuma Y, Dudek D, Smits PC, Koolen J, Chevalier B, de Bruyne B, Thuesen L, McClean D, van Geuns RJ, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Sudhir K, Garcia-Garcia HM, Ormiston JA (2011) Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol 58(15):1578–1588. https://doi.org/10.1016/j.jacc.2011.05.050 CrossRefPubMed

22.

Wurtz M, Christiansen EH, Kristensen SD, Holm NR (2015) Accidentally crushed stent during complex bifurcation treatment. A potential cause of very late stent thrombosis. Int J Cardiol 197:113–115. https://doi.org/10.1016/j.ijcard.2015.06.045 CrossRefPubMed

23.

Koppara T, Cheng Q, Yahagi K, Mori H, Sanchez OD, Feygin J, Wittchow E, Kolodgie FD, Virmani R, Joner M (2015) Thrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully bioabsorbable drug-eluting stents. Circ Cardiovasc Interv 8(6):e002427. https://doi.org/10.1161/CIRCINTERVENTIONS.115.002427 CrossRefPubMed

Title: Procedural findings and early healing response after implantation of a self-apposing bioresorbable scaffold in coronary bifurcation lesions
Authors: Emil Nielsen Holck
Camilla Fox-Maule
Trine Ørhøj Barkholt
Lars Jakobsen
Shengxian Tu
Michael Maeng
Jouke Dijkstra
Evald Høj Christiansen
Niels Ramsing Holm
Publication date: 01-07-2019
Publisher: Springer Netherlands
Published in: The International Journal of Cardiovascular Imaging / Issue 7/2019
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI: https://doi.org/10.1007/s10554-019-01537-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Procedural findings and early healing response after implantation of a self-apposing bioresorbable scaffold in coronary bifurcation lesions

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2019

Ventricular geometry–regularized QRSd predicts cardiac resynchronization therapy response: machine learning from crosstalk between electrocardiography and echocardiography

Subtraction of time-resolved magnetic resonance angiography images improves visualization of the pulmonary veins and left atrium in adults with congenital heart disease: a novel post-processing technique

T1 reactivity as an imaging biomarker in myocardial tissue characterization discriminating normal, ischemic and infarcted myocardium

Predictive value of exercise stress echocardiography in asymptomatic patients with severe aortic regurgitation and preserved left ventricular systolic function without LV dilatation

Predictive value of coronary calcifications for future cardiac events in asymptomatic patients: underestimation of risk in asymptomatic smokers

The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page